ESC Premium Access

Relative bioavailability and pharmacokinetic (PK) performance of a ralinepag extended-release (XR) tablet oral formulation and the effect of food and gender in healthy human subjects

Congress Presentation

About the speaker

Doctor John Adams

Arena Pharmaceuticals, San Diego (United States of America)
0 follower

9 more presentations in this session

Fast screening breath analysis for diagnostics of pulmonary hypertension.

Speaker: Assistant Professor A. Swinarew (Katowice, PL)

Thumbnail

Phenomapping to detect non-invasively patients with combined postcapillary pulmonary hypertension

Speaker: Doctor O. Raitiere (Rouen, FR)

Thumbnail

Impact of comorbidity on outcome in CTD-associated pulmonary arterial hypertension: data from the Swedish Pulmonary Arterial Hypertension Registry

Speaker: Doctor C. Hjalmarsson (Gothenburg, SE)

Thumbnail

Long-term survival and safety with selexipag in patients with pulmonary arterial hypertension: results from the GRIPHON study and its open-label extension

Speaker: Professor N. Galie (Bologna, IT)

Thumbnail

Improved ten-year survival of systemic sclerosis-associated pulmonary arterial hypertension in the contemporary treatment era: a single centre retrospective study of 451 patients.

Speaker: Doctor H. Fayed (London, GB)

Thumbnail

Access the full session

Pulmonary hypertension: progress in management, impact on outcomes

Speakers: Doctor J. Adams, Assistant Professor A. Swinarew, Doctor O. Raitiere, Doctor C. Hjalmarsson, Professor N. Galie...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb